A Phase 3 Randomized, Double-blind, Cross-over, Placebo-controlled, Multi-center, Single-dose, Clinical Trial to Assess the Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers
Phase of Trial: Phase III
Latest Information Update: 02 Jun 2014
Price : $35 *
At a glance
- Drugs Gabapentin (Primary) ; Diphenhydramine; Triazolam
- Indications Epilepsy; Neuralgia; Neuropathic pain
- Focus Adverse reactions; Registrational
- Sponsors Pfizer
- 13 Jan 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 04 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 02 Jul 2013 New trial record